ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1088

Fibromyalgia and Parental Medical Histories Of Depression and Alcoholism

Robert S. Katz1, Ben J. Small2, Sharon M. Ferbert3 and Susan Shott4, 1Rush Medical College, Chicago, IL, 2Rush University Medical School, Chicago, IL, 3Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL, 4Rush University Medical Center, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: alcohol use, depression, family studies and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain II

Session Type: Abstract Submissions (ACR)

Background/Purpose: We had found in a previous study suggestions of an increased prevalence of depression in the mothers and alcohol abuse in the fathers of fibromyalgia patients. We re-examined this finding in a group of fibromyalgia patients.

Methods: 115 FMS patients and 63 control patients with other rheumatic diseases answered a rheumatology office questionnaire that included questions about whether their mother or father had been diagnosed with or had symptoms of depression, alcoholism, or FMS. The chi-square test of association and Fisher’s exact test were used to compare FMS and control patients with respect to percentages. The Mann-Whitney test was done to compare these groups with respect to age. A 0.05 significance level was used and all tests were two-sided.

Results: 81.7% of the FMS patients and 61.9% of the control patients were women (p = 0.004). The mean age was 48.1 ± 12.3 years for FMS patients and 50.7 13.6 for control patients (p = 0.092). 33.0% of FMS patients and 8.1% of control patients reported a depression diagnosis or symptoms in their mothers (p < 0.001). 26.3% of FMS patients reported a depression diagnosis or symptoms in their fathers, compared to 10.0% of control patients (p = 0.013). Although FMS patients were more likely than control patients to report an alcoholism diagnosis or symptoms in their mothers (9.6% vs. 4.8%. p = 0.38) and fathers (19.2% vs. 10.0%, p = 0.18), the differences were not statistically significant. FMS patients were significantly more likely than control patients to report a FMS diagnosis or symptoms in their mothers (26.4% vs. 3.2%. p < 0.001), but not in their fathers (6.2% vs. 0%, p = 0.083).

Conclusion: FMS patients were significantly more likely than control patients to report that their parents had a diagnosis or symptoms of depression, and significantly more likely to report that their mothers had the diagnosis or symptoms of FMS. No statistically significant differences were found with respect to paternal FMS or maternal or paternal alcoholism.


Disclosure:

R. S. Katz,
None;

B. J. Small,
None;

S. M. Ferbert,
None;

S. Shott,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibromyalgia-and-parental-medical-histories-of-depression-and-alcoholism/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology